Broomwell's Telemedical ECG Service Saves an Estimated 144,000 Hospital Referrals

Broomwell HealthWatch, the leading ECG telemedical service provider, has announced it has now completed over 161,000 successful ECG interpretations, in turn preventing around 144,000 referrals to hospitals or diagnostic centres since the service started in 2006.

Broomwell's service enables fast, accurate diagnosis of heart problems by telephone, allowing patients to receive a full 12-lead ECG test at their local GP surgery in minutes. This avoids the inconvenience and expense of patients having to travel to hospitals or diagnostic centres for unnecessary tests. It also relieves pressure on stretched secondary care resources, and means patients don't have to wait up to 21 days for appointments and results.

The service is now handling 1,400 ECG calls per week nationally, with results interpreted by Broomwell's team of expert cardiac clinicians - in turn saving over 1,250 unnecessary hospital referrals every week. The 24-hour, year-round service is being successfully used in GP surgeries, walk-in centres and minor injuries units across almost a large number of PCTs in England, as well as by virtually every PCT in Greater Manchester.

In the past 12 months, Broomwell has provided over 33,000 ECG interpretations in the Greater Manchester area alone. Data from Broomwell's ECG interpretations shows that 90% of symptomatic patients can be managed by their local GP following a diagnosis using the service, without needing to be referred to hospital. This has saved nearly 30,000 hospital referrals in Greater Manchester and, with a single average hospital outpatient appointment costing around £155, this represents a potential saving of over £4.5 million in the Greater Manchester area over the past year alone.

Results from the use of Broomwell's ECG service in the Greater Manchester and Cheshire Cardiac and Stroke Network (GMCCSN) over a two-year period across 9 PCTs in the area, showed that use the service prevented approximately 63% of referrals to secondary care.

Karen Gibbons, Service Improvement Manager at the GMCCSN said: "Preventing such a large percentage of patient referrals to secondary care helps reduce the burden on cardiac resources in hospitals. Providing this sort of expert diagnosis in a primary care setting not only generates cost and resource savings for the NHS, but it's also more convenient for patients and ensures they benefit from timely and preventative care."

Joshua Rowe, CEO of Broomwell HealthWatch, said: "Telemedical ECGs are proving to be very popular with the patients who benefit from the convenience and immediacy of diagnosis, and the reassurance this brings, and also with the GPs and practice staff who are able to make a more informed diagnosis.

"Completing over 161,000 successful ECG telemedical calls and doing some 1,400 ECGs per week translates into very significant cost savings for GP surgeries, Consortia and the NHS. By effectively bringing ECG expertise and services into every surgery, by telephone or email, GPs are able to make an immediate diagnosis, significantly reduce hospital referrals and cut out inconvenience, stress, unnecessary travel and waiting times for people. It's a win-win for GPs, the NHS and patients."

A six-month pilot of cardiac telemedicine services conducted by the Lancashire and South Cumbria Cardiac Network estimated that the service could generate a further national savings of £46 million if rolled out across England by simply avoiding unnecessary referrals to A&E and Admissions.

Broomwell's telemedical services provide PCTs and GPs with 24-hour expert diagnostic support for 12-lead ECGs and Arrhythmia Monitoring from a team of expert cardiac clinicians, enabling patients to receive quick convenient care, closer to home. Practice nurses carry out ECG recordings at the GP surgery and transmit the results over the phone, where a team of expert cardiac clinicians interpret the ECG trace, give an immediate verbal diagnosis, followed by a written report which is sent to the GP within minutes and which can be filled into the standard electronic patient files.

Broomwell also provides Arrhythmia Monitoring services, including a rapid interpretation service for 24-hour tapes and 8-day loop monitors, as well as a Telemedical Monitoring service for congestive heart failure (CHF), congestive heart disease, and chronic obstructive pulmonary disease (COPD).

The company has also introduced its Arrhythmia Watch, which is designed to be worn by patients with suspected arrhythmia and enables them to capture and record episodes as they occur. This further reduces the need for unnecessary hospital visits for diagnostic tests, saving them stress and inconvenience whilst also saving the NHS a significant amount of money.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...